Semaglutide, Tirzepatide, and Type 1 Diabetes: The Data These studies show GLP-1s can have exceptional benefits, including significant weight loss and blood sugar reductions
Other GLP-1 drugs such as Rybelsus, Ozempic, and Mounjaro are approved to treat Type 2 diabetes, but not for the treatment of weight-loss management, even though they have the same active ingredients
The synthetic GLP-1 receptor agonists mimic this endogenous hormone but are modified to resist rapid enzymatic breakdown by dipeptidyl peptidase-4 (DPP-4), thereby extending their duration of action
Fiber-rich, prebiotic foods slow digestion and enhance satiety signals, making it easier to stay in a calorie deficit
With depression as the main issue, providers might increase the dose more quickly if tolerated well